SCHEMBL25313694

SCHEMBL25313694

O=C(O)CC[C@H]1CCNC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.46
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CCR2 P41597 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32
ACE P12821 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25313700 1.00 FOLH1 (0.46) FOLH1TSHRKDM4ENPSR1HDAC6
SCHEMBL29015390 0.89 FOLH1 (0.51) FOLH1TSHRKDM4ECCR2L3MBTL1
SCHEMBL29015392 0.89 FOLH1 (0.51) FOLH1TSHRKDM4ECCR2L3MBTL1
SCHEMBL30222821 0.89 HDAC6 (0.38) FOLH1TSHRHDAC6L3MBTL1ITGB3
SCHEMBL30174805 0.85 KDM4E (0.36) FOLH1TSHRKDM4EHDAC6CCR2
SCHEMBL30222769 0.85 KDM4E (0.36) FOLH1TSHRKDM4EHDAC6CCR2
SCHEMBL24486583 0.83 GAA (0.35) FOLH1TSHRKDM4EHDAC6CCR2
SCHEMBL30170353 0.83 GAA (0.35) FOLH1TSHRKDM4EHDAC6CCR2
SCHEMBL30140824 0.81 CCR2 (0.31) FOLH1CCR2L3MBTL1
Hydrochloric Acid SCHEMBL30192546 0.81 GAA (0.34) FOLH1CCR2L3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380920-A1 INHIBITORS FOR CORONAVIRUSES Cocrystal Pharma, Inc. (US) 2024-06-12 EP disclosed
CN-118103351-A Coronavirus inhibitors 共晶制药公司 2024-05-28 CN disclosed
CN-117769541-A protease inhibitors as antiviral agents 艾森医药有限公司 2024-03-26 CN disclosed
WO-2023125846-A1 COMPOUND FOR PREVENTING AND TREATING CORONAVIRUS INFECTION, CONJUGATE THEREOF AND METHOD THEREFOR 苏州爱科百发生物医药技术有限公司 2023-07-06 WO disclosed
EP-4165037-A1 ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS Aligos Therapeutics, Inc. (US) 2023-04-19 EP disclosed
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 EP disclosed
EP-4132944-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION Cocrystal Pharma, Inc. (US) 2023-02-15 EP disclosed
WO-2023014758-A1 INHIBITORS FOR CORONAVIRUSES COCRYSTAL PHARMA, INC. (US) 2023-02-09 WO disclosed
CN-115698035-A Inhibitors of norovirus and coronavirus replication 共晶制药公司 2023-02-03 CN disclosed
WO-2022266363-A1 PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2022-12-22 WO disclosed
WO-2022265577-A2 CORONAVIRUS ENZYME MODULATORS, METHODS OF SYNTHESIS AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2022-12-22 WO disclosed
CN-114432301-A Covalent inhibitor derivative and application thereof in treating virus infection 北京大学 2022-05-06 CN disclosed